Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8786530 | Clinical Radiology | 2018 | 7 Pages |
Abstract
The APRI is a promising marker to predict treatment response and outcome for HCC patients after TACE treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
T. Tang, J.-L. Qiu, G.-W. Li, M.-P. Huang, Y. Li, Y.-J. Li, S.-Z. Gu,